VEGFA and neoplasm: It was shown that treatment with ESIONPs@EXO resulted in M2 to M1 reprogramming, significantly inhibited vessel formation, reduced endothelial cell sprouting, and suppressed pathological angiogenesis in vivo via VEGF-independent mechanism in the ocular melanoma model, also prohibiting tumor cell proliferation and migration.